Diamox and International normalised ratio increased - a phase IV clinical study of FDA data

Summary:

International normalised ratio increased is reported as a side effect among people who take Diamox (acetazolamide), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Lasix, and have Depression.

The phase IV clinical study analyzes which people have International normalised ratio increased when taking Diamox. It is created by eHealthMe based on reports of 4,260 people who have side effects when taking Diamox from the FDA, and is updated regularly.

What is Diamox?

Diamox has active ingredients of acetazolamide. It is often used in pseudotumor cerebri. eHealthMe is studying from 4,711 Diamox users. Check the latest studies of Diamox.

What is International normalised ratio increased?

International normalised ratio increased is found to be associated with 1,336 drugs and 1,727 conditions by eHealthMe. Check the latest studies of International normalised ratio increased.

On Jul, 29, 2026

4,260 people reported to have side effects when taking Diamox.
Among them, 14 people (0.33%) have International normalised ratio increased.

Could Diamox cause International normalised ratio increased?

Among these 14 people:

How long have people been on Diamox when they have International normalised ratio increased? *

What is the gender of people who have International normalised ratio increased when taking Diamox? *

female: 28.57 %
male: 71.43 %

What is the age of people who have International normalised ratio increased when taking Diamox? *

What are other drugs people take besides Diamox? *

What are other side effects people have besides International normalised ratio increased? *

Haematuria (presence of blood in urine): 7 people, 50.00%
Wheezing (a high-pitched whistling sound made while you breath): 1 person, 7.14%
Cardiac Failure Congestive: 1 person, 7.14%
Fall: 1 person, 7.14%
Faeces Discolored: 1 person, 7.14%
Dyspnea (difficult or laboured breathing): 1 person, 7.14%
Drug Administration Error: 1 person, 7.14%
Dilatation Ventricular: 1 person, 7.14%
Dehydration (dryness resulting from the removal of water): 1 person, 7.14%
Cytolytic Hepatitis (dissolution or destruction of a liver cell): 1 person, 7.14%

What are the existing conditions these people have? *

Depression: 7 people, 50.00%
Respiratory Tract Infection: 1 person, 7.14%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 1 person, 7.14%
Lung Infection: 1 person, 7.14%
Lung Disorder (lung disease): 1 person, 7.14%
Fungal Infection: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Diamox and have International normalised ratio increased?

- Check whether International normalised ratio increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Diamox:

Diamox (4,711 reports)

International normalised ratio increased treatments and more:

International normalised ratio increased (40,071 reports)

How severe was International normalised ratio increased and when was it recovered:

International normalised ratio increased in Diamox

Expand to all the drugs that have ingredients of acetazolamide:

International normalised ratio increased and drugs with ingredients of acetazolamide (24 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Diamox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with International normalised ratio increased:

International normalised ratio increased (1,336 drugs)

Browse all the conditions that are associated with International normalised ratio increased:

International normalised ratio increased (1,727 conditions)

Related publications that referenced our studies

Hu CY, Lee BJ, Cheng HF, Wang CY, "Acetazolamide-related life-threatening hypophosphatemia in a glaucoma patient", Journal of glaucoma, 2015 Apr .
Hu CY, Lee BJ, Cheng HF, Wang CY, "Acetazolamide-related life-threatening hypophosphatemia in a glaucoma patient", Journal of glaucoma, 2015 Apr .

How the study uses the data?

The study uses data from the FDA. It is based on acetazolamide (the active ingredients of Diamox) and Diamox (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.